IGF-1 and insulin as growth hormones

Novartis Foundation Symposium

Volumn 262, Issue , 2004, Pages 56-83

  Laron, Zvi ^a,b   De Myts, ^c  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INSULIN; SOMATOMEDIN C;

ANIMAL; HUMAN; MOUSE; MOUSE MUTANT; PHYSIOLOGY; REVIEW;

ANIMALS; GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, KNOCKOUT;

EID: 16544369608     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (90)

1. Backeljauw PF, Underwood LE 1996 Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome - a clinical Research Center study. GHIS Collaborative Group. J Clin Endocrinol Metab 81:3312-3317
2. Backeljauw PF, Underwood LE, and The GHIS Collaborative Group 2001 Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study. J Clin Endocrinol Metab 86:1504-1510
3. Baker J, Liu J-P, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82
4. Barrett CT, Oliver TK Jr 1968 Hypoglycemia and hyperinsulinism in infants with erythroblastosis fetalis. N Engl J Med 278:1260-1262
5. Baumann G 1997 Growth without a pituitary? - Lessons from the guinea pig. Endocrinology 138:3575-3576
6. Behringer RR, Lewin TM, Quaife CJ, Palmiter RD, Brinster RL, D'Ercole AJ 1990 Expression of insulin-like growth factor-I stimulates normal somatic growth in growth hormone-deficient transgenic mice. Endocrinology 127:1033-1040
7. Bennett ST, Lucassen AM, Gough SC et al 1995 Susceptibility to human type 1 diabetes at IDDM 2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 9:284-292
8. Bikle D, Majumdar S, Laib A et al 2001 The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res 16:2320-2329
9. Brissenden JE, Ullrich A, Francke U 1984 Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor. Nature 310:781-784
10. Bucher H, Zapf J, Torresani T, Prader A, Froesch ER, Illig R 1983 Insulin-like growth factor I and II, prolactin and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma. N Engl J Med 309:1142-1146
11. Camacho-Hubner C, Woods KA, Miraki-Moud F et al 1999 Effects of recombinant human insulin-like factor I (IGF-1) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion. J Clin Endocrinol Metabol 84:1611-1616
12. Dattani MT 2002 GH deficiency might be associated with normal height in PROP1 deficiency. Clin Endocrinol 57:157-158
13. Daughaday WH 1993 Are there direct, non-IGF-I mediated effects of HGH? In: Laron Z, Parks JS (eds) Lessons from Laron Syndrome (LS) 1966-1992. Pediatr Adolesc Endocrinol 24:338-345
14. Daughaday WH, Phillips LS, Mueller MC 1976 The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology 98:214-1219
15. DeBaun MR, King AA, White N 2000 Hypoglycemia in Beckwith-Wiedemann syndrome. Semin Perinatol 24:164-171
16. Dodge JA, Laurence KM 1977 Congenital absence of the pancreas and intrauterine growth retardation. Pediatrics 64:255-257
17. Duvillie B, Corconnier N, Deltour L et al 1997 Phenotypic alterations in insulin-deficient mutant mice. Proc Natl Acad Sci USA 94:5137-5140
18. Enberg B, Luthman H, Segnestam K, Ritzen EM, Sundstorm M, Norstedt G 2000 Characterization of novel missense mutations in the GH receptor gene causing severe growth retardation. Eur J Endocrinol 143:71-76
19. Gafny M, Silbergeld A, Klinger B, Wasserman M, Laron Z 1994 Comparative effects of GH, IGF-I and insulin on serum sex hormone binding globulin. Clin Endocrinol 41:169-175
20. Geffner ME 1996 The growth without growth hormone syndrome. Endocrinol Metab Clin North Am 25:649-663
21. Guevara-Aguirre J, Rosenbloom AL, Vasconez O et al 1997 Two year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor-I in 22 children: comparison of two dosage levels and to GH treated GH deficiency. J Clin Endocrinol Metab 82:629-633
22. Gluckman PD, Gunn AJ, Wray A et al 1992 Congenital idiopathic growth hormone deficiency is associated with prenatal and early postnatal growth failure. J Pediat 121:920-923
23. Green H, Morikawa M, Nixon T 1985 A dual effector theory of growth hormone action. Differentiation 29:195-198
24. Kaneti H, Karasik A, Klinger B, Silbergeld A, Laron Z 1993 Long-term treatment of Laron type dwarfs with insulin-like growth factor I increases serum insulin-like growth factor-binding protein 3 in the absence of growth hormone activity. Acta Endocrinol 128:144-149
25. Kaneti H, Silbergeld A, Klinger B, Karasik A, Baxter RC, Laron Z 1997 Long-term effects of insulin-like growth factor-I (IGF-I) on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein. Eur J Endocrinol 137:626-630
26. Karp M, Laron Z, Doron M 1973 Insulin secretion in children with constitutional familial short stature. J Pediatr 83:241-246
27. Kiepe D, Ulinski T, Powell DR, Durham SK, Mehls O, Tonshoff B 2002 Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes. Kidney Int 62:1591-1600
28. Klinger B, Laron Z 1994 Renal function in Laron syndrome patients treated by insulin-like growth factor-I. Pediatr Nephrol 8:684-688
29. Klinger B, Laron Z 1995 Three year IGF-I treatment of children with Laron Syndrome. J Pediatr Endocrinol Metab 8:149-158
30. Klinger B, Jensen LT, Silbergeld A, Laron Z 1996 Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome. Clin Endocrinol 46:423-429
31. Klinger B, Anin S, Silbergeld A, Eshet R, Laron Z 1998 Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome. Clin Endocrinol 48:81-87
32. Krzisnik C, Battelino T 1997 Five year treatment with IGF-I of a patient with Laron syndrome in Slovenia (a follow-up report). J Pediatr Endocrinol Metab 10: 443-447
33. Laron Z 1981 Insulin as a growth-promoting hormone. In: Collu R, Ducharme J, Guyda H (eds) Pediatric endocrinology. Raven Press, New York, p 149-165
34. Laron Z 1982 Somatomedin, insulin, growth hormone and growth: a review. Isr J Med Sci 18:823-829
35. Laron Z 1993 Laron syndrome: from description to therapy. Endocrinologist 3:21-28
36. Laron Z 1995 Prismatic cases: Laron Syndrome (primary growth hormone resistance). From patient to laboratory to patient. J Clin Endocrinol Metab 80:1526-1573
37. Laron Z 1999a Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome). J Pediatr Endocrinol Metab 12:231-249
38. Laron Z 1999b Somatomedin-1 (recombinant insulin-like growth factor-I). Clinical pharmacology and potential treatment of endocrine and metabolic disorders. BioDrugs 11:55-70
39. Laron Z 2001 Insulin-like growth factor 1 (IGF-1): a growth hormone. J Clin Pathol Mol Pathol 54:311-316
40. Laron Z 2004a Laron syndrome (primary growth hormone resistance or insensitivity). The personal experience 1958-2003. J Clin Endocrinol Metab 89:1031-1044
41. Laron Z 2004b Biologic and clinical aspects of molecular defects along the growth hormone-insulin-like growth factor I axis. Chapter 9. In: Pescovitz OH, Eugster EA (eds). Pediatric endocrinology: mechanisms, manifestations, and management. Lippincott, Williams & Wilkins, Philadelphia, PA, USA, p 123-150
42. Laron Z, Pertzelan A 1969 Somatotrophin in antenatal and perinatal growth and development. Lancet 1:680-681
43. Laron Z, Klinger B 1994 IGF-I treatment of adult patients with Laron syndrome: preliminary results. Clin Endocrinol (Oxf) 41:631-638
44. Laron Z, Klinger B 2000 Comparison of the growth-promoting effects of insulin-like growth factor I and growth hormone in the early years of life. Acta Paediatr 88:38-41
45. Laron Z, Pertzelan A, Kiwity S, Livneh-Zirinsky M, Keret R 1976 Growth without growth hormone: Myth or fact? In: Convegno Internazionale di Endocrinologia Pediatrica, Bologna, June 1975, Pacini, Pisa, p 131-152
46. Laron Z, Volovitz V, Karp M 1977 Linear growth and insulin dose as indices of control in children with diabetes mellitus. In: Laron Z (ed) Medical aspects of balance of diabetes in juveniles. Pediatric and Adolescent Endocrinology. Vol. 2. S. Karger, Basel, p 60-69
47. Laron Z, Ben-Dan I, Shrem M, Dickerman Z, Lilos P 1978 Puberty in simple obese boys and girls. In: Cacciari E, Laron Z, Raiti S (eds) Obesity in childhood. Academic Press, London, p 29-40
48. Laron Z, Anin S, Klipper-Aubach Y, Klinger B 1992a Effects of insulin-like growth factor on linear growth, head circumference and body fat in patients with Laron-type dwarfism. Lancet 339:1258-1261
49. Laron Z, Klinger B, Blum WF, Silbergeld A, Ranke MB 1992b IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I. Clin Endocrinol (Oxf) 36:301-304
50. Laron Z, Suikkari AM, Klinger B et al 1992c Growth hormone and insulin-like growth factor regulate insulin-like growth factor binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature. Acta Endocrinol 127:351-358
51. Laron Z, Anin S, Klinger B 1993a Long-term IGF-I treatment of children with Laron syndrome. In: Laron Z, Parks JS (eds) Lessons from Laron syndrome (LS) 1966-1992. Pediatric and adolescent endocrinology, vol. 24, Karger, Basel-New York, p 226-236
52. Laron Z, Lilos P, Klinger B 1993b Growth curves for Laron syndrome. Arch Dis Child 68:768-770
53. Laron Z, Klinger B, Silbergeld A 1999 Serum insulin-like growth factor-I (IGF-I) levels during long-term IGF-I treatment of children and adults with primary GH resistance (Laron Syndrome). J Pediatr Endocrinol Metab 12:145-152
54. Laron Z, Wang XL, Silbergeld A, Wilcken DEL 1997 Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a). Eur J Endocrinol 136:377-381
55. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr 1996 Molecular biology of the IGF-I receptor. In: Merimee T, Laron Z (eds) Growth hormone, IGF-I and growth. New views of old concepts. Modern Endocrinology and Diabetes. Vol 4. Freund Publishing House Ltd, London-Tel Aviv, p 73-99
56. Lindahl A, Isgaard J, Nilsson A, Isaksson OGP 1986 Growth hormone potentiates colony formation of epiphyseal chondrocytes in suspension culture. Endocrinology 118:1843-1848
57. Lindahl A, Isgaard J, Carlsson L, Isaksson OGP 1987 Differential effects of growth hormone and insulin-like growth factor I on colony formation of epiphyseal chondrocytes in suspension culture in rats of different ages. Endocrinology 121:1061-1069
58. Louvi A, Accili D, Efstratiadis A 1997 Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 189:33-48
59. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A 2001 Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229:141-162
60. Maor G, Silbermann M, von der Mark K, Heingard D, Laron Z 1993 Insulin enhances the growth of cartilage in organ and tissue cultures of mouse neonatal mandibular condyle. Calcif Tissue Int 52:291-299
61. Maor G, Rochwerger M, Segev Y, Phillip M 2002 Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J Bone Miner Res 17:1034-1043
62. Mohan S, Richman C, Guo R et al 2003 Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology 144:929-936
63. Murashita M, Tajima T, Nakae J, Shinohara N, Geffner ME, Fujieda K 1999 Near-normal linear growth in the setting of markedly reduced growth hormone and IGF-I. Horm Res 51:184-188
64. Nakae J, Kido Y, Accili D 2001 Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 22:818-835
65. Nilsson A 1995 Bone growth and metabolism in health and disease. In: Laron Z, Mastragostino S, Romano C, Boero S, Cohen A (eds) Limb lengthening: for whom, when and how? Freund Publishing House, London-Tel Aviv, p 79-91
66. Niwa M, Sato S, Saito Y et al 1986 Chemical synthesis, cloning and expression of genes for human somatomedin C (insulin like growth factor I) and 59Val somatomedin C. Ann NY Acad Sci 469:31-52
67. Powell-Braxton L, Hollingshead P, Warburton C et al 1993 IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617
68. Rajkumar K, Barron D, Lewitt MS, Murphy LJ 1995 Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 136:4029-4034
69. Ranke MB, Savage MD, Chatelain PG et al 1995 Insulin-like growth factor (IGF-I) improves height in growth hormone insensitivity: two years' results. Horm Res 44:253-264
70. Reinecke-Luthge A, Koschoreck F, Kloppel G 2000 The molecular basis of persistent hyperinsulinemic hypoglycemia of infancy and its pathologic substrates. Virchows Arch 436:1-5
71. Rinderknecht E, Humbel RE 1978 The amino acid sequence of human insulin like growth factor I and its structural homology, with proinsulin. J Biol Chem 253:2769-2776
72. Roback EW, Barakat AJ, Dev VG, Mbikay M, Chretien M, Butler MG 1991 An infant with deletion of the distal long arm of chromosome 15 (q26,1qter) and loss of insulin-like growth factor 1 receptor gene. Am J Med Genet 38:74-79
73. Rotwein P, Billiard J, Woelfle J 2002 Molecular physiology of IGF-I expression. J Pediatr Endocrinol Metab 15(suppl 5):1455-1458
74. Salter JM, Best CH 1953 Insulin as growth hormone. Br Med J 2:353-356
75. Schoenle E, Zapf J, Humbel RE, Froesch ER 1982 Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 323:169-171
76. Silbergeld A, Dastot F, Klinger B et al 1997 Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree. J Pediatr Endocrinol Metab 10:265-274
77. Sims EAH, Danforth E Jr 1974 Role of insulin in obesity. Isr J Med Sci 10:1222-1229
78. Sivan B, Lilos P, Laron Z 2003 Effects of insulin-like growth factor -I deficiency and replacement therapy on the hematopoietic system in patients with Laron syndrome (primary growth hormone insensitivity). J Pediatr Endocrinol Metab 16:509-520
79. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF 1997 Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 15:106-110
80. Takahashi Y, Kadowaki H, Momomura K et al 1997 A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism. Diabetologia 40:412-420
81. Tamemoto H, Kadowaki T, Tobe K et al 1994 Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182-186
82. Tamura T, Tohma T, Ohta T et al 1993 Ring chromosome 15 involving deletion of the insulin-like growth factor 1 receptor gene in a patient with features of Silver-Russell syndrome. Clin Dysmorphol 2:106-113
83. Tyrala EE 1996 The infant of the diabetic mother. Obstet Gynecol Clin North Am 23:221-241
84. Van Buul-Offers S, Veda I, van den Brande JL 1986 Biosynthetic somatomedin C (SM-C/IGF-I) increases the length and weight of Snell dwarf mice. Pediatr Res 20:825-827
85. Van Buul-Offers SC, van Kleffens M, Koster JG et al 2000 Human insulin-like growth factor (IGF) binding protein-1 inhibits IGF-I-stimulated body growth but stimulates growth of the kidney in Snell dwarf mice. Endocrinology 141:1493-1499
86. Walker JL, Van Wyk JJ, Underwood LE 1992 Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type). J Pediatr 121:641-646
87. Woods KA, Camacho-Hubner C, Savage MO, Clark AJL 1996 Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363-1367
88. Zapf J, Froesch R, Schmid C 1999 Metabolic effects of IGF's. In: Rosenfeld R, Roberts Jr. C (eds) Contemporary endocrinology: the IGF system. Humana Press Inc, Totowa, NJ, p 577-616
89. Zhang M, Xuan S, Bouxsein ML et al 2002 Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277:44005-44012
90. Zhou Y, Xu BC, Maheshwari HG et al 1997 A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94:13215-13220